Clinical Takeaway
A randomized controlled trial tested the Minder mobile app, co-developed with university students, to address mental health and substance use concerns during the high-risk college transition period. Digital tools like this are being evaluated because they offer scalable, accessible support without requiring in-person clinical visits. Results from this trial provide evidence-based guidance on whether app-based interventions can meaningfully improve outcomes in this vulnerable population.
#4 Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.
Citation: Vereschagin Melissa et al.. Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.. Journal of medical Internet research. 2024. PMID: 38536225.
Design: 5 Journal: 0 N: 3 Recency: 1 Pop: 2 Human: 1 Risk: 0
This randomized controlled trial provides rigorous evidence on whether a student-designed mobile app can effectively reduce mental health and substance use problems during a critical developmental period when these conditions typically emerge. The scalability and accessibility of digital interventions like Minder address a significant clinical gap, as traditional mental health services often cannot meet the demand among university populations. Demonstrating efficacy of this intervention could establish a replicable, cost-effective model for large-scale implementation across academic institutions.
Abstract: BACKGROUND: University attendance represents a transition period for students that often coincides with the emergence of mental health and substance use challenges. Digital interventions have been identified as a promising means of supporting students due to their scalability, adaptability, and acceptability. Minder is a mental health and substance use mobile app that was codeveloped with university students. OBJECTIVE: This study aims to examine the effectiveness of the Minder mobile app in improving mental health and substance use outcomes in a general population of university students. METHODS: A 2-arm, parallel-assignment, single-blinded, 30-day randomized controlled trial was used to evaluate Minder using intention-to-treat analysis. In total, 1489 participants were recruited and randomly assigned to the intervention (n=743, 49.9%) or waitlist control (n=746, 50.1%) condition. The Minder app delivers evidence-based content through an automated chatbot and connects participants with services and university social groups. Participants are also assigned a trained peer coach to support them. The primary outcomes were measured through in-app self-assessments and included changes in general anxiety symptomology, depressive symptomology, and alcohol consumption risk measured using the 7-item General Anxiety Disorder scale, 9-item Patient Health Questionnaire, and US Alcohol Use Disorders Identification Test-Consumption Scale, respectively, from baseline to 30-day follow-up. Secondary outcomes included measures related to changes in the frequency of substance use (cannabis, alcohol, opioids, and nonmedical stimulants) and mental well-being. Generalized linear mixed-effects models were used to examine each outcome. RESULTS: In total, 79.3% (589/743) of participants in the intervention group and 83% (619/746) of participants in the control group completed the follow-up survey. The intervention group had significantly greater average reductions in anxiety symptoms measure
🧠 This randomized controlled trial evaluates a student-codeveloped mobile app for mental health and substance use support during a developmentally vulnerable period, which is encouraging given the scalability advantages of digital interventions. However, several limitations warrant consideration: the study population is restricted to university students, who may differ meaningfully from community populations in baseline mental health literacy, technology comfort, and help-seeking behavior; engagement and adherence data are crucial confounders often underreported in mobile health trials; and the comparison condition (control arm specifications are not detailed in this abstract) will substantially influence effect size interpretation. Additionally, the short-term outcomes typical of app-based studies may not reflect sustained behavior change or clinical outcomes that matter most to patients. For clinicians supporting university-age patients, while digital tools like Minder show promise as accessible adjuncts to traditional care, they should be positioned as supplements to rather than replacements for clinical assessment and direct intervention, particularly for students presenting with moderate to severe mental health or substance use symptoms.